Important reminder: If you need a refill for your essential medication, go straight to the pharmacy (or use mail-order services) instead of contacting your doctor. We will be updating this post as states announce new emergency refill protocols. With fears of limited stock at grocery stores, business closures, and potential quarantine, people are in a...
Tag: <span>COVID-19</span>
Why developing a COVID-19 vaccine is only part of the struggle
by Eric Stirgus Dr. Lilly Immergluck last week gave what she called “the vaccine lecture” to a group of Morehouse School of Medicine students. Immergluck, a pediatrician, infectious disease specialist and an assistant professor at the Atlanta school since 2005, talks each year to all students there about how vaccines have helped control the spread...
If J&J really wants to support nurses, it should make the TB drug bedaquiline affordable
By SASHA CUTTLER, MARY MAGEE, and GUY VANDENBERGMAY 18, 2020 As nurses who worked in 5B, the first U.S. hospital ward dedicated HIV/AIDS, which opened in San Francisco General Hospital in 1983, we have been directly affected in profound ways by the disease and its opportunistic infections. One of us is HIV-positive, infected from exposure...
Butterfly TeleGuidance for Remote Ultrasound Exams During COVID Pandemic
Telemedicine has been around for over a decade in various forms, but the COVID-19 epidemic has turned a convenience into a necessity. Clinical practices that never seriously considered using telemedicine are now performing virtual house calls with their patients. However, although it’s possible to do a lot through a video call, many procedures such as...
COVID-19 causes pulmonary arterial thrombosis and damages other organs as well as the lungs
by Mag. Johannes Angerer, Medical University of Vienna COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas. These are the findings of a first major series of autopsies in Austria, conducted as part...
The new COVID-19 drug remdesivir is here. Now what?
Short supplies and limits on who qualifies mean more options are needed to end the pandemic Remdesivir production Gilead Sciences plans to ramp up production of remdesivir, one of the first antiviral drugs to help COVID-19 patients recover, in order to provide 1 million 10-day course of treatment by year’s end. GILEAD SCIENCES Share this:...
Sociodemographic factors associated with a positive test for COVID-19 in primary care
by Lancet Older age, being male, deprivation, living in a densely populated area, ethnicity, obesity, and chronic kidney disease are associated with a positive test for COVID-19, according to results from 3,802 people tested for SARS-CoV-2 (including 587 positive tests) in the UK. The observational study was conducted in between Jan 28 and April 4...
Continuously active surface disinfectants may provide additional barrier against the spread of viruses
by Rosemary Brandt, University of Arizona In the battle to slow or prevent the transmission of viruses, such as the novel coronavirus, continuously active disinfectants could provide a new line of defense, according to a recent University of Arizona study released on the health sciences preprint server MedRxiv. While disinfecting high-contact surfaces is an important...
Treating skin irritations from wearing face masks
by From Mayo Clinic News Network, Mayo Clinic News Network Since many people are wearing face masks because of COVID-19 pandemic requirements, skin irritations on the face might be more prevalent. “People are getting friction and irritation across their nasal bridge, behind their ears and perhaps under their chin,” says Dr. Dawn Davis, a Mayo...
STUDY: COVID PATIENTS SUFFERING ACUTE KIDNEY DAMAGE
BY VICTOR TANGERMANN / AN HOUR AGO According to a new study conducted at Northwell Health, a large medical system located in New York, over a third of COVID-19 patients experienced acute kidney injury, Reuters reports. “We found in the first 5,449 patients admitted, 36.6% developed acute kidney injury,” Kenar Jhaveri, associated chief of nephrology...